Becton, Dickinson and Company, a global leader in medical supplies, devices, laboratory equipment, and diagnostic products, provides healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide with a wide range of cutting-edge products. The company's BD Medical segment boasts an impressive portfolio of products that includes peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, and IV medication and infusion therapy delivery systems. Additionally, its BD Life Sciences segment offers a variety of state-of-the-art products for specimen and blood collection, rapid diagnostic assays, and fluorescence-activated cell sorters and analyzers. Finally, its BD Interventional segment provides cutting-edge surgical products, surgical infection prevention, peripheral intervention, and urology and critical care products. The 124-year-old company is headquartered in Franklin Lakes, New Jersey, and is committed to providing the highest quality of products and services to its customers.
Becton, Dickinson and Company's ticker is BDX
The company's shares trade on the ASX stock exchange
They are based in Sydney, Australia
There are 11-50 employees working at Becton, Dickinson and Company
It is bd.com/en-us
Becton, Dickinson and Company is in the Healthcare sector